Few RCC Patients Undergo Renal Mass Biopsy Before Surgery

Share this content:
Few RCC Patients Undergo Renal Mass Biopsy Before Surgery
Few RCC Patients Undergo Renal Mass Biopsy Before Surgery

Most patients diagnosed with renal cell carcinoma (RCC) do not undergo renal mass biopsy (RMB) prior to surgery, but most who undergo ablation or systemic therapy do, researchers reported in Urology (2014;83:774-780).

In a study of 24,702 patients diagnosed with RCC from 1992-2007, John T. Leppert, MD, of Stanford University School of Medicine in Palo Alto, Calif., and colleagues documented a steady and modest rise in RMB use, with the greatest use in the final study year. Among the patients who underwent radical or partial nephectomy, 17% and 20%, respectively, underwent RMB in advance of surgery.

RELATED: Renal Cell Carcinoma Resource Center

In addition, 65% of patients who underwent ablation underwent RMB before or in conjunction with the procedure. And just over half (50.4%) of those who received systemic therapy alone underwent RMB.

Factors associated with RMB use included younger age, black race, Hispanic ethnicity, a tumor size smaller than 7 cm, and metastatic disease at presentation.

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs